Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

Simple item page
dc.contributor.authorDillner, Joakim
dc.contributor.authorRebolj, Matejka
dc.contributor.authorBirembaut, Philippe
dc.contributor.authorPetry, Karl-Ulrich
dc.contributor.authorSzarewski, Anne
dc.contributor.authorMunk, Christian
dc.contributor.authorSanjose, Silvia de
dc.contributor.authorNaucler, Pontus
dc.contributor.authorLloveras, Belen
dc.contributor.authorKjaer, Susanne
dc.contributor.authorCuzick, Jack
dc.contributor.authorBallegooijen, Marjolein van
dc.contributor.authorClavel, Christine
dc.contributor.authorIftner, Thomas
dc.date.accessioned2023-01-14T17:36:24Z
dc.date.available2023-01-14T17:36:24Z
dc.date.issued2008-10-13
dc.description.abstractObjective To obtain large scale and generalisable data on the long term predictive value of cytology and human papillomavirus (HPV) testing for development of cervical intraepithelial neoplasia grade 3 or cancer (CIN3+). Design Multinational cohort study with joint database analysis. Setting Seven primary HPV screening studies in six European countries. Participants 24 295 women attending cervical screening enrolled into HPV screening trials who had at least one cervical cytology or histopathology examination during follow-up. Main outcome measure Long term cumulative incidence of CIN3+. Results The cumulative incidence rate of CIN3+ after six years was considerably lower among women negative for HPV at baseline (0.27%, 95% confidence interval 0.12% to 0.45%) than among women with negative results on cytology (0.97%, 0.53% to 1.34%)). By comparison, the cumulative incidence rate for women with negative cytology results at the most commonly recommended screening interval in Europe (three years) was 0.51% (0.23% to 0.77%). The cumulative incidence rate among women with negative cytology results who were positive for HPV increased continuously over time, reaching 10% at six years, whereas the rate among women with positive cytology results who were negative for HPV remained below 3%. Conclusions A consistently low six year cumulative incidence rate of CIN3+ among women negative for HPV suggests that cervical screening strategies in which women are screened for HPV every six years are safe and effective.en_US
dc.identifier.citationDillner, J., Rebolj, M., Birembaut, P., Petry, K. U., Szarewski, A., Munk, C., de Sanjose, S., Naucler, P., Lloveras, B., Kjaer, S., Cuzick, J., van Ballegooijen, M., Clavel, C., Iftner, T., & Joint European Cohort Study (2008). Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ (Clinical research ed.), 337, a1754. https://doi.org/10.1136/bmj.a1754en_US
dc.identifier.otherDOI: 10.1136/bmj.a1754
dc.identifier.urihttps://hdl.handle.net/20.500.14041/5548
dc.language.isoen_USen_US
dc.publisherBMJ (Clinical research ed.)en_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectHuman Papillomavirus Testingen_US
dc.subjectCervical Cancer Screeningen_US
dc.titleLong term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
bmj.a1754.full.pdf
Size:
225.18 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.65 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
SRHR Evidence (Best practice, Systematic reviews)